Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis
Young Eun Chon, Jun Yong Park, Sung-Min Myoung, et al.
The American Journal of Gastroenterology (2017) Vol. 112, Iss. 6, pp. 882-891
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

KASL clinical practice guidelines for management of chronic hepatitis B

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 2, pp. 276-331
Open Access | Times Cited: 89
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih–Lin Lin, Jia‐Horng Kao
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 605-622
Open Access | Times Cited: 40
Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trial
Yufeng Xing, Weichao Zhong, Deti Peng, et al.
Pharmacological Research (2023) Vol. 190, pp. 106737-106737
Open Access | Times Cited: 17
KASL Clinical Practice Guidelines for Noninvasive Tests to Assess Liver Fibrosis in Chronic Liver Disease
Mi Na Kim, Ji Won Han, Jihyun An, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. Suppl, pp. S5-S105
Open Access | Times Cited: 6
Interpretation of liver stiffness measurement‐based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2‐year prospective study
Xie Liang, Qing Xie, Dianhui Tan, et al.
Journal of Viral Hepatitis (2017) Vol. 25, Iss. 3, pp. 296-305
Closed Access | Times Cited: 41
Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Guanghua Rong, Yong‐Ping Chen, Zujiang Yu, et al.
The Journal of Infectious Diseases (2020) Vol. 225, Iss. 6, pp. 1091-1099
Open Access | Times Cited: 33
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review
Luca Rinaldi, Chiara Giorgione, Andrea Mormone, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1730-1730
Open Access | Times Cited: 13
Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
Han Ah Lee, Hyun Woong Lee, Yeon Seok Seo, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B
Dong Ji, Yan Chen, Qinghua Shang, et al.
The American Journal of Gastroenterology (2021) Vol. 116, Iss. 8, pp. 1676-1685
Open Access | Times Cited: 27
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Markus Cornberg, Lisa Sandmann, Jerzy Jaroszewicz, et al.
Journal of Hepatology (2025)
Closed Access
Systematic review with meta-analysis: Change in liver stiffness during anti-viral therapy in patients with hepatitis B
Antonio Facciorusso, Herney Andrés García‐Perdomo, Nicola Muscatiello, et al.
Digestive and Liver Disease (2018) Vol. 50, Iss. 8, pp. 787-794
Closed Access | Times Cited: 28
Pharmacokinetics and pharmacodynamics of pegylated interferon for the treatment of hepatitis B
Ming‐Lun Yeh, Jee‐Fu Huang, Chia‐Yen Dai, et al.
Expert Opinion on Drug Metabolism & Toxicology (2019) Vol. 15, Iss. 10, pp. 779-785
Closed Access | Times Cited: 27
Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
Yi‐Wen Huang, Chao‐Wei Hsu, Sheng‐Nan Lu, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 997-1008
Open Access | Times Cited: 27
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
Tung‐Hung Su, Chun‐Hsun Liao, Chen‐Hua Liu, et al.
Radiology (2018) Vol. 288, Iss. 1, pp. 293-299
Closed Access | Times Cited: 26
Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78‐week prospective study
Xiaoqin Dong, Zhao Wu, ­Jun Li­, et al.
Journal of Gastroenterology and Hepatology (2018) Vol. 34, Iss. 4, pp. 755-763
Closed Access | Times Cited: 25
Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection
Ming Xiong, Junying Li, Shuling Yang, et al.
Clinical and Translational Gastroenterology (2019) Vol. 10, Iss. 10, pp. e00085-e00085
Open Access | Times Cited: 23
Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment
Shengdi Wu, Li‐Li Liu, Jilin Cheng, et al.
Clinical and Experimental Medicine (2018) Vol. 18, Iss. 3, pp. 433-443
Closed Access | Times Cited: 19
Impacts of cigarette smoking on liver fibrosis and its regression under therapy in male patients with chronic hepatitis B
Ming Xiong, Junying Li, Shuling Yang, et al.
Liver International (2019) Vol. 39, Iss. 8, pp. 1428-1436
Closed Access | Times Cited: 15
FibroScan Predicts Liver Fibrosis Progression in Chronic HBV Infection Patients with No Clear Indication for Antiviral Therapy: A Retrospective Cohort Study
Wei Xu, Qiankun Hu, Chong Chen, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 1777-1785
Open Access | Times Cited: 4
Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
Heejin Cho, Yun Bin Lee, Yeonjung Ha, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
Jae Seung Lee, Tae Seop Lim, Hye Won Lee, et al.
Diagnostics (2022) Vol. 13, Iss. 1, pp. 3-3
Open Access | Times Cited: 7
Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study
Hariklia Kranidioti, Konstantinos Zisimopoulos, Theodora Oikonomou, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis
Jung Il Lee, Hyun Woong Lee, Seung Up Kim, et al.
Cancers (2019) Vol. 11, Iss. 3, pp. 425-425
Open Access | Times Cited: 9
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B
Do Young Kim, Dong Jin Joo, Yong‐ho Lee, et al.
Digestive and Liver Disease (2020) Vol. 52, Iss. 11, pp. 1338-1345
Closed Access | Times Cited: 9
Association of α-fetoprotein levels with liver stiffness measurement in outpatients with chronic hepatitis B
Juan Wang, Pengpeng Zhang, Juan Liao, et al.
Bioscience Reports (2020) Vol. 41, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top